Company news

Olema Pharmaceuticals, Inc. news in 2025

Olema Pharmaceuticals, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference

November 20, 2025

Olema Oncology Announces Closing of $218.5 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

November 19, 2025

Olema Oncology Announces Pricing of $190.0 Million Public Offering of Common Stock

November 18, 2025

Olema Oncology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

November 17, 2025

Olema Oncology Reports Third Quarter 2025 Financial and Operating Results

November 9, 2025

Olema Oncology to Present Trial-in-Progress Poster for Phase 3 OPERA-02 Trial of Palazestrant Plus Ribociclib at SABCS 2025

October 29, 2025

Olema Oncology Announces New Data from the Phase 1b/2 Trial of Palazestrant Plus Ribociclib in ER+/HER2- Metastatic Breast Cancer at ESMO 2025

October 17, 2025

Olema Oncology Announces New Clinical Trial Agreement with Pfizer to Combine Palazestrant with Atirmociclib in ER+/HER2- Metastatic Breast Cancer

September 1, 2025

Olema Oncology Reports Second Quarter 2025 Financial and Operating Results

August 10, 2025

Olema Oncology Announces Palazestrant Dose Selection and Trial-in-Progress Poster at ASCO 2025 Annual Meeting

May 27, 2025

Olema Oncology Reports First Quarter 2025 Financial and Operating Results

May 12, 2025

Olema Oncology Announces New Preclinical Data for OP-3136 Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at AACR 2025

April 24, 2025

Olema Oncology to Present Preclinical Data for OP-3136, a Potent KAT6 Inhibitor, Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at the 2025 AACR Annual Meeting

March 24, 2025

Olema Oncology Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

March 17, 2025

Olema Oncology to Present at the TD Cowen 45th Annual Health Care Conference

February 18, 2025

Olema Oncology Appoints Shawnte M. Mitchell, J.D. as Chief Legal Officer and Corporate Secretary

February 17, 2025

Olema Oncology to Present at 43rd Annual J.P. Morgan Healthcare Conference

January 1, 2025

Decks in 2025